PARP Inhibitors in Prostate Cancer- Who, When, and Why (not)
0% Complete
Course Overview
NA
Course Content
Course Details
- Duration
- 0.00 hour
- Released
- May 14, 2025
- Last Review
- May 14, 2025
- Expires
- May 14, 2028
Objectives
NA
Target Audience
NA
Faculty & Disclosure
Faculty
Ravi A. Madan, MD
Disclosure
Ravi A. Madan, MD discloses no such relationships exist
Accreditation
NA
Related Courses
2025 Advances in Oncology | Metastatic Prostate Cancer Therapeutic Landscape: From Biology to Changing Standards of Care
0.00 AMA PRA Category 1 Credits™
1 Chapter
Prostate
Free
2025 Advances in Oncology | Metastatic Hormone Sensitive and Castration Resistant Prostate Cancer in 2025: Longer and Better life
0.00 AMA PRA Category 1 Credits™
1 Chapter
Prostate
Free